Test 2

Please select your preferred language.

請選擇你慣用的語言。

请选择你惯用的语言。

English
中文简体
台灣繁體
香港繁體

Login

Remember Me

New to Fridae?

Fridae Mobile

Advertisement
Highlights

More About Us

Fresh : Blogs

Recent Blog Posts

TraceyC

Work-Life Balance Tips for Busy Entrepreneurs and Business Owners

TraceyC - 6 hours ago

As a business owner or entrepreneur, it can be challenging to maintain a balance between your work and personal life. The demands of running a business can often take priority over your personal responsibilities and well-being. 

However, finding a balance between the two is crucial for both your professional and personal success. If you’re having problems with these things, here are ten tips and strategies for achieving a healthy work-life balance as a busy entrepreneur or business owner

Prioritize your time

Make a list of the most important tasks that you need to complete each day, and focus on those first. This will help you to stay on track and ensure that you are using your time effectively. 

Also, this will help you do more work in less time, and that’s going to leave you with more free time once you get home from work. Therefore, this is a win-win solution all entrepreneurs and business owners are hoping for in the long run.

Set boundaries

It can be easy for work to take over your life when you are a business owner or entrepreneur. To prevent this from happening, set clear boundaries between your work and personal life. This might mean setting specific times when you will not check your email or work on projects, or it might mean creating a designated workspace in your home where you can focus on your business without distractions.

Practice self-care

Taking care of yourself is essential for maintaining a healthy work-life balance. Make sure that you are getting enough sleep, eating well, and getting regular exercise. You may also want to consider incorporating a few innovative mindfulness practices - meditation or yoga, for instance - into your daily routine to help you stay grounded and focused.

Learn to delegate

As a business owner or entrepreneur, it can be hard to let go of control and trust others to handle certain tasks. However, delegation is an important skill to master if you want to maintain a healthy work-life balance. By delegating some of your responsibilities to others, you will have more time to focus on the things that truly matter.

Make time for hobbies and interests

One of the most important aspects of maintaining a healthy work-life balance is making time for the things that you enjoy. Whether it's spending time with family and friends, pursuing a hobby, or taking a vacation, make sure that you are taking the time to do the things that bring you joy and fulfillment.

Use technology to your advantage

Technology can be a powerful tool for managing your time and staying organized. Consider using a calendar or task management app to help you stay on top of your to-do list, or a time-tracking app to help you see where you are spending the most time. You can also use a practical sugar dating app that’s going to help you find someone special in your life and manage your love life more easily and efficiently.

Flexible work schedule

Every entrepreneur and business owner should consider implementing a flexible work schedule. This would allow them to have some control over their schedule so they can attend to their personal life responsibilities.

Learn to say no from time to time

One of the biggest challenges of being a business owner or entrepreneur is learning to say no. It can be hard to turn down opportunities, but it's important to remember that you can't do everything. Be selective about the projects and commitments that you take on, and don't be afraid to say no if something doesn't align with your goals or values.

Take some time off

This is one of the most important things you can do to maintain a healthy work-life balance, and it’s all about taking some time off as often as possible. This means taking a vacation, taking a day off, or even just taking a long weekend. It's important to disconnect from work and give yourself the time and space to relax, recharge, and reconnect with your loved ones.

Seek support

Entrepreneurship can be a lonely journey, and it's important to seek support when you need it. Whether it's talking to a mentor, joining a business group, or seeking the advice of a therapist, make sure that you have a support system in place to help you navigate the ups and downs of running a business.

In conclusion, maintaining a healthy work-life balance as a business owner or entrepreneur can be a challenge, but it's essential for your well-being and the success of your business. By using these tips and turning them into reality, you can create a balance that works for you!

kylie1

Driven by the growing demand for medical devices, novel coatings providing unique features are being introduced in the market

kylie1 - 10 hours ago

Over the past 50 years, the medical device industry has seen several notable developments. In fact, the use of biomedical devices, such as medical implants, surgical instruments, and prostheses has increased substantially over the time.

Cardioverter defibrillators, prosthetic hips and knees, contact lenses, and cardiac pacemakers are some of the most commonly implanted medical devices, while fixation devices and artificial joints account for about 44% of all medical devices. Despite significant advancements in the design and implantation of medical devices, a number of challenges still persist. Patients, particularly those who are immunocompromised, are at high risk of healthcare-associated infections (HAIs) due to the in-dwelling nature of implanted devices and surgical tools. The risk of infections along with limitations including, implant rejection, osseointegration, degradation and wear, loom over the prosthetic integration. Coatings on biomedical implants can affect this biological interaction between the implant and host, mitigate joint wear, and combine the properties of several materials to enhance device performance as well as reduce the risks associated with invasive medical devices. Medical device coatings also endow properties like lubrication, anti-fouling nature, as well as enhanced durability to the surface of the device. Driven by the surge in demand for various types of medical devices and the need for a wide array of coatings for these devices, the medical device coatings market is anticipated to witness a steady growth in the coming decade.

 

To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/medical-device-coatings-market/request-sample.html

 

One of the key challenges associated with in-dwelling medical devices lies in the fact that they are in constant association with the bodily fluids, therefore, interacting with a wide variety of proteins and other biomolecules. This results in denaturization of the biomaterials over time, reducing the overall functional life of the device. As a counter to this problem, surface modification can be utilized. Generally, protein adsorption and biological interactions are significantly impacted by the biomaterial surface modifications, such as modifying the chemistry of polymers, coefficient of friction, domain layout, and shape. Surface modifications, such as plasma spraying, vacuum depositions, etching, and electro-depositions are some of the most frequently procedures to achieve the necessary alterations on medical device surfaces.

 

Various medical devices are associated with the risk of infections, cytotoxicity, thrombogenesis, and immune rejection, which has garnered the attention towards appropriate selection of suitable biomaterials and strategies for modifying the medical devices surface. One of the key developments in the area has been made in creating non-fouling / antibacterial surfaces.  A breakthrough in this field has been witnessed in graphene coatings developed to elicit antimicrobial properties. As an alternative to the use of silver nanoparticles earlier, the use of graphene in healthcare applications has a promising future, given the fact that graphene would provide more secure antibacterial properties than metal nanoparticles along with cost efficiency.  The detailed competitiveness analysis of various medical device coating providers identified during our research, which are based in North America, Europe, and Asia.

 

Integration of new technologies like advanced laser processing, machine learning, and automation using Artificial Intelligence (AI) also drives the field towards more precise and reproducible coating / surface treatment applications, which can revolutionize the biomedical devices industry.

 

For additional details, please visit https://www.rootsanalysis.com/reports/medical-device-coatings-market.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Targeted protein degradation market, 2022-2035

2.     Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035

                       

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

 

Contact:

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com

 

 

ct_vision

杨宝得环 (Yang Bo is Rewarded)

ct_vision - 2 days ago

Last year on 3 Feb 2022, on the 3rd day of the Tiger Year I was feeling lost. I went to the Pak Sing Ancestral Hall in Sheung Wan after brunch with a friend. We had no plans and spontaneously went in to ask about our love lives. I came out with a very positive lot. A small little slip of paper with the story of 杨宝得环 (Yang Bo is Rewarded) and a little red wrist band. I honestly am surprise that my wish and prayer came through. I can’t be happier at the moment and I look forward to returning this coming Sat on 4 Feb 2023, on the 13th day of the new Rabbit Year to give thanks.

 

 Story of杨宝得环 (Yang Bo is Rewarded)

Yang Bao was from Hongnong County in the Han Dynasty. When he was nine years old, Yang Bao was in the north of Huayin Mountain when he saw an oriole that was injured by an owl and fell under a tree. A group of ants surrounded the injured oriole. Yang Bao took pity on the oriole, took it home, placed it in a small wooden box, and fed it with chrysanthemums every day.  After more than 100 days, the oriole's injury was healed and its feathers were fully grown. It flew out every morning and came back at night. One night, after midnight, Yang Bao was still reading and not sleeping.  Suddenly, a young man dressed in yellow came to pay homage to Yang Bao again and again, and he said to Yang Bao, "I am the envoy of the Queen Mother of the Western Heaven, and I was ordered to go to Penglai Xianshan as an envoy, and I was accidentally injured by an owl. Thanks for your love and help, and thank you very much for your kindness.  After speaking, the youth in yellow gave Yang Bao four white jade rings, and said, "Let your descendants be as noble as this white jade, and be ranked among the third princes."

 

Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market, 2022 – 2040 report to its list of offerings.

 

Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential therapeutic agents for the treatment of neurological disorders across various preclinical studies and early stages of clinical development, worldwide. With the ongoing pace of innovation in this field, increasing R&D activity and promising pre-clinical data, several promising leads are anticipated to be commercially launched over the coming decade and SARM1 targeting therapeutics market is anticipated to witness substantial growth in the mid to long-term. 

 

Key Market Insights  

 

Presently, several SARM1 targeting therapy candidates are being developed by various industry players

About 65% of the pipeline candidates are currently being evaluated in the preclinical stages of development, followed by those currently in the discovery stage (35%). Further, it is worth mentioning that close to 85% of the SARM1 inhibitors are small molecules.

 

Currently, a number of companies claim to be engaged in the development of SARM1 inhibitors

The SARM1 inhibitors market is dominated by the presence of large companies (81%), followed by small players (19%). In addition, around 20% of the players were established post-2010.

 

120+ articles related to SARM1 inhibitors have been published between 2011 and 2022

Majority (81%) of the articles published in this domain were research papers, followed by review papers (12%). It is important to note that more than 70% of the total number of articles were published post-2018.

 

Over 30 grants have been awarded for research related to SARM1 inhibitors, since 2014

Close to 40% of the total amount was awarded under the R01 mechanism (which supports research projects). Further, genetics and neurology emerged as the key research departments, having received 34% of the total grants, each.

 

70+ patents related to SARM1 targeting therapeutics have been filed / granted till 2022

Over the years, the number of patents filed for SARM1 inhibitors has increased gradually; majority of the patents have been filed / granted in 2021. Most of the patents in this domain are patent applications (96%), followed by granted patents (3%).

 

North America is anticipated to capture more than 65% share of the market, by 2040

By 2040, the market revenues are likely to be driven by the sales of small molecules (95%) being developed as SARM1 inhibitors. Further, sales of therapeutics targeting multiple sclerosis are likely to contribute to a majority share (~40%) of revenues, in the long term.

 

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/sarm1-inhibitors-market/request-sample.html

 

Key Questions Answered

§  Who are the leading players engaged in the development of SARM1 targeting therapeutics?

§  What is the evolving trend of publications focused on SARM1 targeting therapeutics?

§  How is the intellectual property landscape in this field likely to evolve in the foreseen future?

§  What are the recent developments and strategic initiatives undertaken by players engaged in this market space related to the research and development of SARM1 targeting therapeutics?

§  What are the key value drivers that are likely to influence the evolution of this upcoming market?

§  How is the current and future market opportunity likely to be distributed across key market segments?

 

The financial opportunity within the SARM1 targeting therapeutics market has been analyzed across the following segments:

 

§  Type of Molecule

§  Small Molecules

§  Biologics

 

§  Target Indication

§  Multiple Sclerosis

§  Peripheral, Central and Ocular Nervous System Disorders

§  Peripheral Neuropathies

§  Glaucoma

§  Amyotrophic Lateral Sclerosis

 

§  Drug Developers

§  Company 1

§  Company 2

§  Company 3

 

§  Drug Candidates

§  Drug Candidate 1

§  Drug Candidate 2

§  Drug Candidate 3

§  Drug Candidate 4

§  Drug Candidate 5

§  Drug Candidate 6

 

§  Key Geographies 

§  North America

§  Europe

 

The research includes detailed profiles of key players (listed below); featuring an overview of the company, financial information (if available), details related to its product portfolio, patent portfolio, recent developments (including partnerships and collaborations) and an informed future outlook.

§  Disarm Therapeutics

§  Nura Bio

§  Washington University

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/sarm1-inhibitors-market.html

or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.       RNAi Market: Therapeutics and Technologies (Focus on siRNA, miRNA, shRNA and DNA) (3rd Edition): Industry Trends and Global Forecasts, 2022-2035

2.       Global Therapeutic Vaccines Market: Industry Trends and Global Forecasts, 2022-2035

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

 

kylie1

AI-BASED DIGITAL PATHOLOGY GAINS INTEREST DUE TO AUTOMATION, DIGITIZATION OF HEALTHCARE, SHORTAGE OF PATHOLOGISTS, AND INCREASED DEMAND FOR PATHOLOGY SERVICES

kylie1 - 1 week ago

In recent years, advancements in technology and emphasis on precision medicine have recently paved the path for the development of artificial intelligence (AI) based digital pathology techniques for quantitative and qualitative assessment of samples.

Specifically, the process of AI-based digital pathology allows scanning of slides via computer monitors, by replacing the conventional microscopic approaches. Further, by converting glass slides to images, samples can be transmitted from diagnostic centers to pathologists within a fraction of time. Considering the rising popularity and demand for such solutions in the healthcare and research industry, and the ongoing efforts of AI-powered digital pathology solution providers / AI pathology solution providers to further improve / expand their respective portfolios, we believe that the AI-based digital pathology market /  AI Pathology Market is likely to evolve at a steady pace, till 2035.

 

To request a sample copy / brochure of this report, please visit this

https://www.rootsanalysis.com/reports/ai-based-digital-pathology-market/request-sample.html

 

The steps involved in the usual workflow of AI-based digital pathology process.

 

§  Preparation of Tissue Sample: This process is very similar to the conventional approach. A pathologist examines a biopsy to determine its color, size and consistency. At this point, the specialist can detect symptoms of malignancy and select which areas of a specimen should be inspected under the microscope. Further, the chosen region is prepared by following multi-step processes, such as treatment of the tissue with chemicals in order to maintain its structure, mounting the specimen on a glass slide, staining to improve contrast and protecting the tissue with coverslips.

 

§  Converting into Virtual Sample / Whole slide imaging (WSI): WSI or virtual microscopy is a technique that is used to enable digital pathology. Its central component, which is a WSI scanner, captures a picture of the glass slide and generates a precise electronic replica known as a virtual slide. It is worth noting that virtual slides, unlike glass slides, are easy to replicate, save, categorize and distribute. Furthermore, they may be linked to electronic health records, thereby, providing a complete picture of a patient's health.

 

§  Saving a Virtual Slide: The scanner pre-processes the virtual slide automatically and stores it to on-premises or cloud storage. In order to minimize the file size, a compression approach is frequently employed before saving the slide.

 

§  Viewing and Editing of Slide: In the digital process, instead of using a traditional microscope, a pathologist uses a computer display to analyze enlarged tissue samples. A slide viewing and management software is used to zoom out a tissue segment and observe its smallest features. In addition, this software allows the pathologist to view the slide from different angles, add annotations and even compare multiple images at one time.

 

§  Sharing Data: Using specialized digital pathology software applications, slides are converted to an electronic format, thereby, allowing them to be exchanged using the internet. These slides can be shared to gain a second opinion, as well as with patients, research facilities and other stakeholders.

 

§  Reporting Results: Some image viewing systems provide reporting capabilities. However, this work is often accomplished by enabling interaction with the laboratory information or laboratory information management system (LIS/LIMS) and hospital information system (HIS).

 

The digital revolution of pathology is projected to accelerate in the coming years, considering multiple growth drivers, including growing number of laboratories adopting high throughput digital scanning and software technologies to assist diagnostic practice. In addition, factors, including shortage of skilled pathologists in remote areas, increasing pathology workloads due to ageing populations, higher rate of cancer screening programs, rising complexity of pathology testing and time constraints, and requirement for pathology labs to outsource expertise in the field, also contributes significantly towards the need for AI-based digital pathology solutions.

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/ai-based-digital-pathology-market.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.      Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035

2.      4D Bioprinting Market : Industry Trends and Global Forecasts, 2022-2035

 

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

                       

Contact:

Ben Johnson

+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

 

 

kylie1

The smart pharmaceutical and healthcare labels market is anticipated to grow at a CAGR of 16%, till 2035, claims Roots Analysis

kylie1 - 1 week ago

In order to overcome the limitations and challenges related to counterfeit drugs, researchers and industry stakeholders are gradually adopting smart pharmaceutical and healthcare labels, which offer multiple benefits over conventional labels.

Roots Analysis has announced the addition of “Smart Pharmaceutical and Healthcare Labels Market, 2022-2035” report to its list of offerings.

 

A smart label comprises of printed information, a bar code identifier and a small transponder. This transponder contains a processing chip and an antenna that allows physical objects to communicate with the tag reader (for instance, RFID reader). Smart labels offer several benefits, such as tracing and tracking products in a supply chain, tamper proofing, as well as discouraging counterfeiters from packaging fake drugs. In this context, it is worth mentioning that smart labelling technology can potentially save USD 0.8 - 1.5 million per year, per company, through their applications in inventory management.

 

 

Key Market Insights

 

More than 90 companies claim to offer smart pharmaceutical and healthcare labels, globally

This segment of the industry is dominated by the presence of mid-sized (51-500 employees) and small (less than 50 employees) players, which collectively represent more than 75% of the total smart label providers in pharmaceutical and healthcare sectors. Further, ~20% of firms were established post-2010.

 

400+ patents related to smart pharmaceutical and healthcare labels were filed / granted, since 2015

Based on intellectual property distribution across the world, R&D activity related to smart pharmaceutical and healthcare labels is largely concentrated in North America (over 65%), followed by Europe (10%). In addition, most of the patents have been granted patent (55%), followed by patent applications (44%).

 

Partnership activity in this domain has increased at a significant pace, between 2018 and 2022

The recent partnerships trend in this market indicates the growing interest of industry stakeholders. It is worth highlighting that majority of the deals were service alliances, representing around 41% of the total number of partnerships signed in the given time period.

 

North America and Europe are anticipated to capture over 65% of the market share by 2035

The markets in Asia-Pacific and Latin America are anticipated to grow at a relatively faster pace. In the long-term, the aforementioned regions are expected to collectively represent 33% of the total market share. In addition, RFID based smart labels are likely to capture more than 75% of the market share in 2035.

 

To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/smart-labels-market/request-sample.html

 

Key Questions Answered

§  Who are the leading players engaged in the development of smart pharmaceutical and healthcare labels?

§  What is the relative competitiveness of different smart pharmaceutical and healthcare labels providers?

§  Which types of partnership models are most commonly being adopted by stakeholders engaged in this domain?

§  What are the key strategies that can be implemented by emerging players / start-ups to enter the highly competitive market for smart labels for the healthcare sector?

§  Which companies are actively filing patents to drive innovation in the field of smart pharmaceutical and healthcare labels?

§  What are the key challenges within the smart pharmaceutical and healthcare labels market?

§  What is the current / likely future market size of smart pharmaceutical and healthcare labels?

 

 

The financial opportunity within the smart pharmaceutical and healthcare labels market has been analyzed across the following segments:

 

§  Type of Technology

§  RFID

§  NFC

§  Other Technologies

 

§  Type of packaging

§  Primary Packaging

§  Secondary Packaging

 

§  Type of Primary Packaging

§  Vials

§  Syringes

§  Cartridges

§  Ampoules

§  Bottles

§  Blister Packs

 

§  Type of Secondary Packaging

§  Boxes

§  Cartons

§  Pouches

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  MENA

§  Latin America

 

The report includes detailed profiles of key players (listed below) engaged in providing smart pharmaceutical and healthcare labels; each profile features an overview of the developer, details related to smart labels focused product portfolio, recent developments and an informed future outlook:

§  CCL Industries

§  Schreiner

§  Datalogic

§  Tadbik

§  SATO

§  Invengo

§  Intellhydro Technology

§  RFiD Discovery

§  ID Tech Solutions

 

For additional details, please visit https://www.rootsanalysis.com/reports/smart-labels-market.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Pharmaceutical Secondary Packaging Market: Industry Trends and Global Forecast, 2022-2035

2.     AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Contact:

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

 

kylie1

The liposome development and manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis

kylie1 - 1 week ago

 

Driven by the development of advanced methods for preparation and characterization of liposomes, and the application of these molecules in therapeutics and diagnostics, the demand for liposomes is expected to rise in the coming years.

 

London

 

Roots Analysis has announced the addition of “Liposome Manufacturing Market, 2022-2035” report to its list of offerings.

 

Despite the growing interest in liposome-based therapeutics and diagnostics, the development and manufacturing of liposomes is associated with several challenges, including complex manufacturing processes, huge capital investments, inadequate clinical grade production and GMP compliant industrial scale-up, lack of facilities with necessary infrastructure, as well as concerns related to storage and stability. In order to deal with the aforementioned challenges, a number of pharmaceutical companies have demonstrated the preference to outsource their respective liposome development and manufacturing operations to specialized service providers.

 

Key Market Insights

 

More than 70 companies are currently offering services related to liposome development and manufacturing, globally 

Majority (74%) of the service providers offer formulation development services for liposomes. This is followed by players offering analytical method development (65%), liposome contract manufacturing (64%), and process development (61%) services.

 

Close to 6,100 articles focused on liposomes, have been published in reputed scientific journals, since 2017

More than 50% of the articles focused on liposomes were published post-2019. Popular journals that have published multiple articles include International Journal of Pharmaceutics, Journal of Controlled Release, and Pharmaceutics.

 

More than 800 clinical trials have been registered for the evaluation of liposome-based therapeutics, worldwide

The clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 17%, during the period 2017-2021. Of the total number of trials registered, 60% have already been completed, while 26% of the studies are actively recruiting participants. 

 

Nearly 700 patents related to liposomes have been filed / granted, since 2017

Owing to the increase in research and development efforts led by several industry and non-industry players engaged in this domain, close to 55% of patent applications have been filed post-2016. It is worth noting that 61% patents related to liposomes were filed / granted in the US alone.

 

Over 110 global events related to liposomes were organized in the past couple of years

Majority (63%) of the events related to liposomes, were organized virtually in order to comply with the guidelines in the ongoing COVID-19 pandemic. Further, the agendas of the events organized post-2020 include discussions on the applications, and recent advancements in technologies associated with liposomes.

 

Go / No-Go framework can be used to assist players in the crucial outsourcing decision-making process

The framework enables evaluation of the current capabilities of liposome-based therapeutic developers, based on 4+ parameters, including trial phase, target therapeutic area, location of trial(s), patient enrollment and willingness to outsource.

 

North America is anticipated to capture over 40% of the global market share for liposome development and manufacturing services, by 2035 

In terms of type of product formulation, the therapeutic formulations of liposomes (71%) are anticipated to capture the highest share, this trend is unlikely to change in the foreseen future. Further, based on end users, majority of the revenue share (76%) of the overall market is likely to be driven by pharmaceutical and biotechnology industry, by 2035. 

 

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market/request-sample.html

                                                                                     

Key Questions Answered

§  Who are the key players offering liposome development and manufacturing services?

§  What is the evolving trend of publications focused on liposomes?

§  How many patents, related to liposomes, have been filed / granted in the past few years?

§  Which companies are actively involved in conducting clinical trials for liposomes?

§  What are the key agenda items being discussed in various global events / conferences related to liposomes?

§  Which factors are likely to influence the decision of liposome manufacturing being done in-house or outsourced?

§  How is the current and future market opportunity related to liposome development and manufacturing services, likely to be distributed across key market segments?

 

The financial opportunity within the liposome development and manufacturing services market has been analyzed across the following segments:

§  Type of Product Formulation

§  Therapeutic

§  Nutraceutical

 

§  Scale of Operation

§  Discovery / Research

§  Preclinical

§  Clinical

§  Commercial

 

§  End User

§  Pharmaceutical and Biotechnology Industry

§  Cosmetic Industry

§  Food Industry

§  Agricultural Industry

§  Academics

§  Other Industries

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Middle East and North Africa

§  Latin America

 

The research also includes detailed profiles of the key players (listed below) offering services for liposome development and manufacturing; each profile features an overview of the company, its financial information (if available), details on service portfolio, recent developments and an informed future outlook.

§  Baxter BioPharma Solutions

§  Charles River Laboratories

§  Evonik

§  Fresenius Kabi

§  Fujifilm

§  GEA

§  Intertek

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/liposome-manufacturing-market.html

or email sales@rootsanalysis.com

                                                                                                                                               

You may also be interested in the following titles:

1.     Biologics Fill Finish Services Market (3rd Edition), 2022-2035

2.     Bioavailability Enhancement Technologies and Services Market, 2022-2035

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

                       

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

 

IndyBear69

Kiss me

IndyBear69 - 1 week ago

Don't kiss me like we are married, kiss me like we are lovers

pettytriff

你好

pettytriff - 2 weeks ago

我是來找另一半的 我喜歡亞洲、優雅、英俊的男性。 讓我們互相了解一下。 我來自羅馬尼亞的克盧日納波卡。 我知道我離你很遠。 而且我也有一個缺點,我只會說羅馬尼亞語。 但我還是想完成我的夢想。

hugu

萍聚

hugu - 2 weeks ago
Sexagenarian

Life Is A Journey

Sexagenarian - 2 weeks ago

“When you were born, you were crying and everyone else was smiling. Live your life so at the end, your're the one who is smiling and everyone else is crying.”

Sexagenarian

Getting Old

Sexagenarian - 2 weeks ago

"You have to embrace getting old. Life is precious and when you've lost a lot of people, you realize that each day is a gift."

Lizbo

Nerve wracking day😅

Lizbo - 3 weeks ago

Why?

Cos its meet her parents day... was really nervous. All went well.

 

Lizbo

The journey 💑

Lizbo - 3 weeks ago

You said -let's go for late night supper at Macdonalds again...

You like to eat Mac? I asked. 

Nope- you said..

I just enjoy our journey back home...with you holding my hands and we chatting casually... very simple but i loved it💕

james831aj

Bidding farewell to 2022

james831aj - 1 month ago

31 December 2022 Sunny morning 07:58a.m.

In a blink, 2022 passed through the passage of time.

It has been a good year, though I wish it could be better.

I spent quality time with my mum. This is the best thing I have gained in 2022.

Still alone; did not meet any guy or have sex with anyone. I haven't have sex since 2018 at least. 

What is there for me in 2023? I pray for a healthy, smooth-going, joyful, peaceful year. It will be a bonus if I meet someone in 2023.

Happy New Year to all my Fridae friends.

Thank you for walking this journey with me for 2022.

 

 

BB23

Ed Sheeran - Shivers

BB23 - 1 month ago
I took an arrow to the heart
I never kissed a mouth that tastes like yours
Strawberries and somethin' more
Ooh yeah, I want it all
Lipstick on my guitar (ooh)
Fill up the engine, we can drive real far
Go dancin' underneath the stars
Ooh yeah, I want it all
Mm, you got me feelin' like
I wanna be that guy, I wanna kiss your eyes
I wanna drink that smile, I wanna feel like I'm
Like my soul's on fire, I wanna stay up all day and all night
Yeah, you got me singin' like
Ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back
And we'll say, ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back
Into the car
On the backseat in the moonlit dark
Wrap me up between your legs and arms
Ooh, I can't get enough
You know you could tear me apart (ooh)
Put me back together and take my heart
I never thought that I could love this hard
Ooh, I can't get enough
Mm, you got me feeling like
I wanna be that guy, I wanna kiss your eyes
I wanna drink that smile, I wanna feel like I'm
Like my soul's on fire, I wanna stay up all day and all night
Yeah, you got me singin' like
Ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back
And we'll say, ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back
Baby, you burn so hot
You make me shiver with the fire you got
This thing we started, I don't want it to stop
You know you make me shiver-er-er
Baby, you burn so hot
You make me shiver with the fire you got
This thing we started, I don't want it to stop
You know you make me shiver
Yeah, you got me singin' like
Ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back (oh no)
And we'll say, ooh, I love it when you do it like that
And when you're close up, give me the shivers
Oh baby, you wanna dance 'til the sunlight cracks
And when they say the party's over, then we'll bring it right back, hey
james831aj

Another lonely Christmas has passed

james831aj - 1 month ago

26 Dec 2022 Monday Sunny 12:41 p.m.

Another Christmas has passed. Still alone. The only companion are my mum and the lighting on the streets. Otherwise, Christmas is just like any day.

I feel sad, ever time when there is festive season. I do appreciate celebrating the festive seasons with my mother, but somehow, I feel empty in my my heart. I see posts in media, couples together, spending the festive season together. I am envious. How I wish, i wake up on Christmas day, naked and cuddling with a man. Perhaps we wake up together and make love to start the day. How nice and sweet feeling.

Christmas has passed. Time to welcome the new year. Hope 2023 will be a good year.

Lizbo

Keys to my heart ❤ 1st Christmas

Lizbo - 1 month ago

You told me the key chains you buy for us will be the key chain for our future house keys....

Had a simple celebration for Maxwell's birthday and spend our 1st Christmas together... Nothing grand.. jus simple cozy time together...

 

hksar

Christmas Eve 2022

hksar - 1 month ago

"也许一个勇敢的决定 能换两个重生的约定
“我们到了站” 这一站叫终于"

 

终于结束的起点 - 五月天

Search Personals

I am
Interested In
For
Age to
Country
State
  • Online now
  • With photo
  • Photo vault
  • Safe sex
  • New

Featured Profiles

Now ALL members can view unlimited profiles!

Languages

View this page in a different language:

Like Us on Facebook

Partners

 ILGA Asia - Fridae partner for LGBT rights in Asia IGLHRC - Fridae Partner for LGBT rights in Asia

Advertisement